Trials / Completed
CompletedNCT00931190
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
Evaluation of the Use of Human Papillomavirus Persistence for Determination of the Treatment Efficacy Among Women With Cervical Intraepithelial Neoplasia, and for Prediction of Recurrence of Cervical Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 195 (actual)
- Sponsor
- Lund University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objectives are to evaluate the effectiveness of treatment of cervical intraepithelial neoplasia (CIN) by loop electrosurgical excision procedure using persistence of human papillomavirus (HPV) as outcome, and to perform a long-term follow-up on the ability of HPV testing, as compared to cytology, to predict recurrence of high-grade CIN.
Detailed description
Cervical samples for human papillomavirus (HPV) DNA analysis and cytological analysis were obtained from women with abnormal smears referred to Umeå university hospital, Sweden, for treatment with conization. These women were scheduled for HPV DNA testing and Pap smears before and 3, 6, 12, 24 and 36 months after treatment. The HPV DNA testing was performed with a PCR-based genotyping method.
Conditions
Timeline
- Start date
- 2001-02-01
- Completion
- 2005-11-01
- First posted
- 2009-07-02
- Last updated
- 2009-09-15
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00931190. Inclusion in this directory is not an endorsement.